Ratings RadNet, Inc.

Equities

RDNT

US7504911022

Market Closed - Nasdaq 04:00:00 2024-05-16 pm EDT 5-day change 1st Jan Change
57.58 USD -1.13% Intraday chart for RadNet, Inc. +7.49% +65.60%

Summary

  • The company presents an interesting fundamental situation from a short-term investment perspective.

Strengths

  • The earnings growth currently anticipated by analysts for the coming years is particularly strong.
  • Over the last twelve months, the sales forecast has been frequently revised upwards.
  • Over the last 4 months, analysts have significantly revised upwards the company's estimated sales.
  • For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.
  • For the last few months, EPS revisions have remained quite promising. Analysts now anticipate higher profitability levels than before.
  • Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
  • The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
  • Predictions on business development from analysts polled by Standard & Poor's are tight. This results from either a good visibility into core activities or accurate earnings releases.

Weaknesses

  • The company sustains low margins.
  • With an expected P/E ratio at 122.51 and 74.3 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
  • The company is highly valued given the cash flows generated by its activity.
  • The average consensus view of analysts covering the stock has deteriorated over the past four months.
  • The company's earnings releases usually do not meet expectations.

Ratings chart - Surperformance

Chart ESG Refinitiv

Sector: Healthcare Facilities & Services

1st Jan change Capi. Investor Rating ESG Refinitiv
+65.60% 4.3B
C+
-15.71% 8.57B
B+
-9.46% 2.47B -
-2.16% 2.46B
B-
-44.11% 2.31B
B-
-7.42% 1.93B
C-
-18.68% 1.53B
A-
-41.75% 1.2B
C+
+11.31% 1.14B
B+
+16.15% 986M
B-
Investor Rating
Trading Rating
ESG Refinitiv

Financials

Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances
-

Valuation

P/E ratio
EV / Sales
-
Price to Book
-
Price to Free Cash Flow
Yield
-

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality

Environment

Emissions
Innovation
Use of resources

Social

Social commitment
Human Rights
Product liability
Human Resources

Governance

CSR Strategy
Management
Shareholders

Controversy

Controversy

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW